Health experts argue that there are tactics that payers and purchasers can deploy to help improve patient access.
Cardinal Health Specialty Solutions and KEW Group agree to make KEW's diagnostic services available to Specialty Solutions' community oncology customers.
Drug Store News director of continuing education and clinical content Suzanne Feeney, PharmD, will take over the Drug Store News twitter handle @drugstorenews, as part of the global #Pharmacist tweet-a-thon on Thursday, Oct. 2.
Boehringer Ingelheim Pharmaceuticals announced that the Food and Drug Administration approved Spiriva Respimat (tiotropium bromide) inhalation spray as a treatment for bronchospasm associated with chronic obstructive pulmonary disease.
Actavis on Friday confirmed that it has filed an abbreviated new drug application with the Food and Drug Administration to market buprenorphine transdermal system, a generic version of Butrans from Purdue Pharma.
Camber Pharmaceuticals announced the launch of raloxifene hydrochloride, USP tablets in 60-mg dosage strengths.
Celgene Corp. earlier this week announced that the Food and Drug Administration approved Otezla (apremilast) for the treatment of moderate to severe plaque psoriasis. The drug is the first and only PDE4 inhibitor approved for the treatment of plaque psoriasis, according to the company.
AbbVie on Thursday announced that the Food and Drug Administration approved Humira (adalimumab) as a treatment for pediatric Crohn's disease patients ages 6 years and older when other treatments haven't worked well enough.
Want satisfied pharmacy customers? Ensure that they have direct interaction and collaboration with pharmacists and implement an in-store clinic or wellness center.
In honor of the 30th anniversary of the Drug Price Competition and Patent Term Restoration Act — more commonly known as the Hatch Waxman Act — which enabled manufacturers to bring generic versions of pharmaceuticals to market more easily, GPHA president Ralph Neas issued a statement.